BPI Editors

Latest from BPI Editors

BPI Theater presenter
Information Technology
Developing a Fully Integrated, Digitally Controlled, Intelligent Production Manufacturing Line for xRNADeveloping a Fully Integrated, Digitally Controlled, Intelligent Production Manufacturing Line for xRNA
byBPI Editors
Jul 31, 2024
BPI Theater presenters
Supply Chain
Introducing the Next Generation of High-Performance Protein A ResinIntroducing the Next Generation of High-Performance Protein A Resin
byBPI Editors
Jul 31, 2024

All from BPI Editors

BPI Theater presenter
Information Technology
The Ultimate Interface for Drug Discovery: How Spatial Computing and AI Agents Are Transforming How We Understand Molecules
The Ultimate Interface for Drug Discovery: How Spatial Computing and AI Agents Are Transforming How We Understand Molecules
Jul 31, 2024
byBPI Editors
BPI Theater presenter
PAT
The Latest Analytical Technologies and Approaches for Bioprocessing
The Latest Analytical Technologies and Approaches for Bioprocessing
Jul 31, 2024
byBPI Editors
BPI Theater presenter
Continuous Bioprocessing
Opportunities and Challenges in Developing a Fully Connected Continuous Manufacturing Process for Biologics
Opportunities and Challenges in Developing a Fully Connected Continuous Manufacturing Process for Biologics
Jul 31, 2024
byBPI Editors
BPI Theater presenter
Risk Management
What Unseen Trouble Lies Within Your Processes?
What Unseen Trouble Lies Within Your Processes?
Jul 31, 2024
byBPI Editors
BPI Theater presenter
Continuous Bioprocessing
Overcoming Challenges of Batch Manufacturing with Fully Connected Continuous Manufacturing
Overcoming Challenges of Batch Manufacturing with Fully Connected Continuous Manufacturing
Jul 31, 2024
byBPI Editors
Facility Design/Engineering
BPI Theater Interview: Alex Del Priore, Senior Vice President of Manufacturing Services, Syngene International
BPI Theater Interview: Alex Del Priore, Senior Vice President of Manufacturing Services, Syngene International
Jul 31, 2024
byBPI Editors
BPI Theater presenter
Cell Line Development
A View of the Future for Manufacturing Viral Vectors
A View of the Future for Manufacturing Viral Vectors
Jul 31, 2024
byBPI Editors
Facility Design/Engineering
BPI Theater Interview: Kevin Sharp, Senior Vice President and Head of Global Sales, Samsung Biologics
BPI Theater Interview: Kevin Sharp, Senior Vice President and Head of Global Sales, Samsung Biologics
Jul 31, 2024
byBPI Editors
BPI Theater presenter
Gene Therapies
Seamless Viral-Vector Technology Transfer at Any Phase: Offering Stability in Times of Change
Seamless Viral-Vector Technology Transfer at Any Phase: Offering Stability in Times of Change
Jul 31, 2024
byBPI Editors
Facility Design/Engineering
BPI Theater Interview: Benedikt von Braunmühl, Chief Executive Officer, Rentschler Biopharma
BPI Theater Interview: Benedikt von Braunmühl, Chief Executive Officer, Rentschler Biopharma
Jul 31, 2024
byBPI Editors
Supply Chain
BPI Theater Interview: Hayley Crowe, Executive Vice President and General Manager of Global Life Sciences, Purolite (Ecolab)
BPI Theater Interview: Hayley Crowe, Executive Vice President and General Manager of Global Life Sciences, Purolite (Ecolab)
Jul 31, 2024
byBPI Editors
Cell Line Development
BPI Theater Interview: J.D. Mowery, President and Chief Executive Officer, KBI Biopharma
BPI Theater Interview: J.D. Mowery, President and Chief Executive Officer, KBI Biopharma
Jul 31, 2024
byBPI Editors
Bioreactors
BPI Theater Interview: Nick Jackowetz, Senior Vice President and Principal Scientist, Hydrosome Labs
BPI Theater Interview: Nick Jackowetz, Senior Vice President and Principal Scientist, Hydrosome Labs
Jul 31, 2024
byBPI Editors
Continuous Bioprocessing
BPI Theater Interview: Himanshu Gadgil, Chief Executive Officer, Enzene Biosciences
BPI Theater Interview: Himanshu Gadgil, Chief Executive Officer, Enzene Biosciences
Jul 31, 2024
byBPI Editors
Facility Design/Engineering
BPI Theater Interview: Steve Lavezoli, Vice President of Biologics, Curia Global
BPI Theater Interview: Steve Lavezoli, Vice President of Biologics, Curia Global
Jul 31, 2024
byBPI Editors
David Jen presenting
Continuous Bioprocessing
Strategies for Integrated Development and Manufacturing: Adapting Batch Platforms and Facilities for Multimodal Biopharmaceutical Production and Continuous Processing
Strategies for Integrated Development and Manufacturing: Adapting Batch Platforms and Facilities for Multimodal Biopharmaceutical Production and Continuous Processing
Jul 31, 2024
byBPI Editors
BPI Theater presenter
Continuous Bioprocessing
Continuous Biomanufacturing for Increasing Access to Biologics
Continuous Biomanufacturing for Increasing Access to Biologics
Jul 31, 2024
byBPI Editors
Dawn Ecker presenting
Supply Chain
Biomanufacturing Supply and Demand: Industry Trends and Projected Impacts
Biomanufacturing Supply and Demand: Industry Trends and Projected Impacts
Jul 31, 2024
byBPI Editors
business people shaking hands
From the Editor
From the Editor: Business Operations
From the Editor: Business Operations
Jul 30, 2024
byBPI Editors
scientist with bottle
From the Editor
From the Editor: Advanced Therapies
From the Editor: Advanced Therapies
Jul 30, 2024
byBPI Editors
scientist holding small vial
From the Editor
From the Editor: Drug Product
From the Editor: Drug Product
Jul 29, 2024
byBPI Editors
scientist at tank
From the Editor
From the Editor: Drug Substance
From the Editor: Drug Substance
Jul 29, 2024
byBPI Editors

Webinars

Register for this webcast
ATE Webcasts
Register Now: Reliable Data, Reliable Products -- Maintaining Data Integrity in Bioprocessing WorkflowsRegister Now: Reliable Data, Reliable Products -- Maintaining Data Integrity in Bioprocessing Workflows
Repligen slide 1
Sponsored Content
More Product Faster: Maximize mAbs, Cell Therapy, and Gene Therapy Production with Upstream Process IntensificationMore Product Faster: Maximize mAbs, Cell Therapy, and Gene Therapy Production with Upstream Process Intensification
WuXi Biologics slide 1
Sponsored Content
Advanced Analytical Strategies: From Protein Structure Characterization to Potency Assessment for Challenging Biologic ModalitiesAdvanced Analytical Strategies: From Protein Structure Characterization to Potency Assessment for Challenging Biologic Modalities
Insider News
See all
Sep 23 - Sep 26, 2024
Learn from the brightest minds in bioprocessing! The BPI US 2024 scientific agenda includes 200+ of the industry's top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production.
Learn More

Innovative Technology

Valgenesis transforming pharmaceutical development
Sponsored Content
Transforming Pharmaceutical Development: Combining Digital Platforms and QbD PrinciplesTransforming Pharmaceutical Development: Combining Digital Platforms and QbD Principles
byBPI Contributor
Aug 7, 2024
1 Min Read
Thermo Fisher Scientific TrypLE
Sponsored Content
Gibco TrypLE Select Enzyme: An Alternative to Animal Trypsin for Cell DissociationGibco TrypLE Select Enzyme: An Alternative to Animal Trypsin for Cell Dissociation
byBPI Contributor
Jul 31, 2024
1 Min Read
thumbnail
Sponsored Content
Single-Use Upstream Processing: Ultimus® Film Delivers Comparable Cell Growth Performance To GlassSingle-Use Upstream Processing: Ultimus® Film Delivers Comparable Cell Growth Performance To Glass
byBPI Contributor
Jul 24, 2024
1 Min Read